ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Continuous Pharma Production Lines Market Research Report 2026
Published Date: 2026-03-30
|
Report Code: QYRE-Auto-18T17365
Home | Market Reports
Global Continuous Pharma Production Lines Market Research Report 2024
BUY CHAPTERS

Global Continuous Pharma Production Lines Market Research Report 2026

Code: QYRE-Auto-18T17365
Report
2026-03-30
Pages:144
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GEA Group
Glatt Group
IMA Group
LB Bohle
Hovione
Continuus Pharmaceuticals
Syntegon
Repligen
Dec Group
Recipharm
Shionogi
SK Biotek
KORSCH
Chemtrix
Fette Compacting
Gericke
Thermo Fisher Scientific
Coperion
Siemens AG
Copa-Data
Asymchem Laboratories (Tianjin)
Porton Pharma Solutions
Zhejiang Canaan Tech

Continuous Pharma Production Lines Market

The global Continuous Pharma Production Lines market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Continuous Pharma Production Line is a manufacturing system designed to produce pharmaceutical products in a seamless, uninterrupted flow. Unlike traditional batch processing, where production occurs in discrete steps and materials may be held between stages, continuous production integrates all stages of the manufacturing process, from the input of raw materials to the output of finished products, into a single, ongoing operation.
Continuous manufacturing in the pharmaceutical oral solid dosage industry offers substantial benefits, e.g., increased quality, cost savings, flexibility, operator safety and advantages in research and development. A 24/7 processing time is possible. All these advantages are so substantial, that the US Food and Drug Administration (FDA) promotes the development and introduction of continuous process concepts actively in pharmaceutical manufacturing.
The North American market for Continuous Pharma Production Lines is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Continuous Pharma Production Lines is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Continuous Pharma Production Lines in Pharmaceutical Companies is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Continuous Pharma Production Lines include GEA Group, Glatt Group, IMA Group, LB Bohle, Hovione, Continuus Pharmaceuticals, Syntegon, Repligen, Dec Group, Recipharm, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Continuous Pharma Production Lines market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Continuous Pharma Production Lines. The Continuous Pharma Production Lines market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Continuous Pharma Production Lines market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Continuous Pharma Production Lines manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Continuous Pharma Production Lines Market Report

Report Metric Details
Report Name Continuous Pharma Production Lines Market
Segment by Type
  • Integrated Systems
  • Modular Systems
Segment by Application
  • Pharmaceutical Companies
  • Contract Manufacturing Organization
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GEA Group, Glatt Group, IMA Group, LB Bohle, Hovione, Continuus Pharmaceuticals, Syntegon, Repligen, Dec Group, Recipharm, Shionogi, SK biotek, Korsch, Chemtrix, Fette Compacting, Gericke, Thermo Fisher Scientific, Coperion, Siemens, Copa-DATA, Asymchem Laboratories(Tianjin), Porton Pharma Solutions, Zhejiang Canaan Tech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Continuous Pharma Production Lines companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Continuous Pharma Production Lines Market report?

Ans: The main players in the Continuous Pharma Production Lines Market are GEA Group, Glatt Group, IMA Group, LB Bohle, Hovione, Continuus Pharmaceuticals, Syntegon, Repligen, Dec Group, Recipharm, Shionogi, SK biotek, Korsch, Chemtrix, Fette Compacting, Gericke, Thermo Fisher Scientific, Coperion, Siemens, Copa-DATA, Asymchem Laboratories(Tianjin), Porton Pharma Solutions, Zhejiang Canaan Tech

What are the Application segmentation covered in the Continuous Pharma Production Lines Market report?

Ans: The Applications covered in the Continuous Pharma Production Lines Market report are Pharmaceutical Companies, Contract Manufacturing Organization

What are the Type segmentation covered in the Continuous Pharma Production Lines Market report?

Ans: The Types covered in the Continuous Pharma Production Lines Market report are Integrated Systems, Modular Systems

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Continuous Pharma Production Lines Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Integrated Systems
1.2.3 Modular Systems
1.3 Market by Application
1.3.1 Global Continuous Pharma Production Lines Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Pharmaceutical Companies
1.3.3 Contract Manufacturing Organization
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Continuous Pharma Production Lines Market Perspective (2021–2032)
2.2 Global Continuous Pharma Production Lines Growth Trends by Region
2.2.1 Global Continuous Pharma Production Lines Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Continuous Pharma Production Lines Historic Market Size by Region (2021–2026)
2.2.3 Continuous Pharma Production Lines Forecasted Market Size by Region (2027–2032)
2.3 Continuous Pharma Production Lines Market Dynamics
2.3.1 Continuous Pharma Production Lines Industry Trends
2.3.2 Continuous Pharma Production Lines Market Drivers
2.3.3 Continuous Pharma Production Lines Market Challenges
2.3.4 Continuous Pharma Production Lines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Continuous Pharma Production Lines Players by Revenue
3.1.1 Global Top Continuous Pharma Production Lines Players by Revenue (2021–2026)
3.1.2 Global Continuous Pharma Production Lines Revenue Market Share by Players (2021–2026)
3.2 Global Top Continuous Pharma Production Lines Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Continuous Pharma Production Lines Revenue
3.4 Global Continuous Pharma Production Lines Market Concentration Ratio
3.4.1 Global Continuous Pharma Production Lines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Continuous Pharma Production Lines Revenue in 2025
3.5 Global Key Players of Continuous Pharma Production Lines Head Offices and Areas Served
3.6 Global Key Players of Continuous Pharma Production Lines, Products and Applications
3.7 Global Key Players of Continuous Pharma Production Lines, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Continuous Pharma Production Lines Breakdown Data by Type
4.1 Global Continuous Pharma Production Lines Historic Market Size by Type (2021–2026)
4.2 Global Continuous Pharma Production Lines Forecasted Market Size by Type (2027–2032)
5 Continuous Pharma Production Lines Breakdown Data by Application
5.1 Global Continuous Pharma Production Lines Historic Market Size by Application (2021–2026)
5.2 Global Continuous Pharma Production Lines Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Continuous Pharma Production Lines Market Size (2021–2032)
6.2 North America Continuous Pharma Production Lines Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Continuous Pharma Production Lines Market Size by Country (2021–2026)
6.4 North America Continuous Pharma Production Lines Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Continuous Pharma Production Lines Market Size (2021–2032)
7.2 Europe Continuous Pharma Production Lines Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Continuous Pharma Production Lines Market Size by Country (2021–2026)
7.4 Europe Continuous Pharma Production Lines Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Continuous Pharma Production Lines Market Size (2021–2032)
8.2 Asia-Pacific Continuous Pharma Production Lines Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Continuous Pharma Production Lines Market Size by Region (2021–2026)
8.4 Asia-Pacific Continuous Pharma Production Lines Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Continuous Pharma Production Lines Market Size (2021–2032)
9.2 Latin America Continuous Pharma Production Lines Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Continuous Pharma Production Lines Market Size by Country (2021–2026)
9.4 Latin America Continuous Pharma Production Lines Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Continuous Pharma Production Lines Market Size (2021–2032)
10.2 Middle East & Africa Continuous Pharma Production Lines Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Continuous Pharma Production Lines Market Size by Country (2021–2026)
10.4 Middle East & Africa Continuous Pharma Production Lines Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GEA Group
11.1.1 GEA Group Company Details
11.1.2 GEA Group Business Overview
11.1.3 GEA Group Continuous Pharma Production Lines Introduction
11.1.4 GEA Group Revenue in Continuous Pharma Production Lines Business (2021–2026)
11.1.5 GEA Group Recent Development
11.2 Glatt Group
11.2.1 Glatt Group Company Details
11.2.2 Glatt Group Business Overview
11.2.3 Glatt Group Continuous Pharma Production Lines Introduction
11.2.4 Glatt Group Revenue in Continuous Pharma Production Lines Business (2021–2026)
11.2.5 Glatt Group Recent Development
11.3 IMA Group
11.3.1 IMA Group Company Details
11.3.2 IMA Group Business Overview
11.3.3 IMA Group Continuous Pharma Production Lines Introduction
11.3.4 IMA Group Revenue in Continuous Pharma Production Lines Business (2021–2026)
11.3.5 IMA Group Recent Development
11.4 LB Bohle
11.4.1 LB Bohle Company Details
11.4.2 LB Bohle Business Overview
11.4.3 LB Bohle Continuous Pharma Production Lines Introduction
11.4.4 LB Bohle Revenue in Continuous Pharma Production Lines Business (2021–2026)
11.4.5 LB Bohle Recent Development
11.5 Hovione
11.5.1 Hovione Company Details
11.5.2 Hovione Business Overview
11.5.3 Hovione Continuous Pharma Production Lines Introduction
11.5.4 Hovione Revenue in Continuous Pharma Production Lines Business (2021–2026)
11.5.5 Hovione Recent Development
11.6 Continuus Pharmaceuticals
11.6.1 Continuus Pharmaceuticals Company Details
11.6.2 Continuus Pharmaceuticals Business Overview
11.6.3 Continuus Pharmaceuticals Continuous Pharma Production Lines Introduction
11.6.4 Continuus Pharmaceuticals Revenue in Continuous Pharma Production Lines Business (2021–2026)
11.6.5 Continuus Pharmaceuticals Recent Development
11.7 Syntegon
11.7.1 Syntegon Company Details
11.7.2 Syntegon Business Overview
11.7.3 Syntegon Continuous Pharma Production Lines Introduction
11.7.4 Syntegon Revenue in Continuous Pharma Production Lines Business (2021–2026)
11.7.5 Syntegon Recent Development
11.8 Repligen
11.8.1 Repligen Company Details
11.8.2 Repligen Business Overview
11.8.3 Repligen Continuous Pharma Production Lines Introduction
11.8.4 Repligen Revenue in Continuous Pharma Production Lines Business (2021–2026)
11.8.5 Repligen Recent Development
11.9 Dec Group
11.9.1 Dec Group Company Details
11.9.2 Dec Group Business Overview
11.9.3 Dec Group Continuous Pharma Production Lines Introduction
11.9.4 Dec Group Revenue in Continuous Pharma Production Lines Business (2021–2026)
11.9.5 Dec Group Recent Development
11.10 Recipharm
11.10.1 Recipharm Company Details
11.10.2 Recipharm Business Overview
11.10.3 Recipharm Continuous Pharma Production Lines Introduction
11.10.4 Recipharm Revenue in Continuous Pharma Production Lines Business (2021–2026)
11.10.5 Recipharm Recent Development
11.11 Shionogi
11.11.1 Shionogi Company Details
11.11.2 Shionogi Business Overview
11.11.3 Shionogi Continuous Pharma Production Lines Introduction
11.11.4 Shionogi Revenue in Continuous Pharma Production Lines Business (2021–2026)
11.11.5 Shionogi Recent Development
11.12 SK biotek
11.12.1 SK biotek Company Details
11.12.2 SK biotek Business Overview
11.12.3 SK biotek Continuous Pharma Production Lines Introduction
11.12.4 SK biotek Revenue in Continuous Pharma Production Lines Business (2021–2026)
11.12.5 SK biotek Recent Development
11.13 Korsch
11.13.1 Korsch Company Details
11.13.2 Korsch Business Overview
11.13.3 Korsch Continuous Pharma Production Lines Introduction
11.13.4 Korsch Revenue in Continuous Pharma Production Lines Business (2021–2026)
11.13.5 Korsch Recent Development
11.14 Chemtrix
11.14.1 Chemtrix Company Details
11.14.2 Chemtrix Business Overview
11.14.3 Chemtrix Continuous Pharma Production Lines Introduction
11.14.4 Chemtrix Revenue in Continuous Pharma Production Lines Business (2021–2026)
11.14.5 Chemtrix Recent Development
11.15 Fette Compacting
11.15.1 Fette Compacting Company Details
11.15.2 Fette Compacting Business Overview
11.15.3 Fette Compacting Continuous Pharma Production Lines Introduction
11.15.4 Fette Compacting Revenue in Continuous Pharma Production Lines Business (2021–2026)
11.15.5 Fette Compacting Recent Development
11.16 Gericke
11.16.1 Gericke Company Details
11.16.2 Gericke Business Overview
11.16.3 Gericke Continuous Pharma Production Lines Introduction
11.16.4 Gericke Revenue in Continuous Pharma Production Lines Business (2021–2026)
11.16.5 Gericke Recent Development
11.17 Thermo Fisher Scientific
11.17.1 Thermo Fisher Scientific Company Details
11.17.2 Thermo Fisher Scientific Business Overview
11.17.3 Thermo Fisher Scientific Continuous Pharma Production Lines Introduction
11.17.4 Thermo Fisher Scientific Revenue in Continuous Pharma Production Lines Business (2021–2026)
11.17.5 Thermo Fisher Scientific Recent Development
11.18 Coperion
11.18.1 Coperion Company Details
11.18.2 Coperion Business Overview
11.18.3 Coperion Continuous Pharma Production Lines Introduction
11.18.4 Coperion Revenue in Continuous Pharma Production Lines Business (2021–2026)
11.18.5 Coperion Recent Development
11.19 Siemens
11.19.1 Siemens Company Details
11.19.2 Siemens Business Overview
11.19.3 Siemens Continuous Pharma Production Lines Introduction
11.19.4 Siemens Revenue in Continuous Pharma Production Lines Business (2021–2026)
11.19.5 Siemens Recent Development
11.20 Copa-DATA
11.20.1 Copa-DATA Company Details
11.20.2 Copa-DATA Business Overview
11.20.3 Copa-DATA Continuous Pharma Production Lines Introduction
11.20.4 Copa-DATA Revenue in Continuous Pharma Production Lines Business (2021–2026)
11.20.5 Copa-DATA Recent Development
11.21 Asymchem Laboratories(Tianjin)
11.21.1 Asymchem Laboratories(Tianjin) Company Details
11.21.2 Asymchem Laboratories(Tianjin) Business Overview
11.21.3 Asymchem Laboratories(Tianjin) Continuous Pharma Production Lines Introduction
11.21.4 Asymchem Laboratories(Tianjin) Revenue in Continuous Pharma Production Lines Business (2021–2026)
11.21.5 Asymchem Laboratories(Tianjin) Recent Development
11.22 Porton Pharma Solutions
11.22.1 Porton Pharma Solutions Company Details
11.22.2 Porton Pharma Solutions Business Overview
11.22.3 Porton Pharma Solutions Continuous Pharma Production Lines Introduction
11.22.4 Porton Pharma Solutions Revenue in Continuous Pharma Production Lines Business (2021–2026)
11.22.5 Porton Pharma Solutions Recent Development
11.23 Zhejiang Canaan Tech
11.23.1 Zhejiang Canaan Tech Company Details
11.23.2 Zhejiang Canaan Tech Business Overview
11.23.3 Zhejiang Canaan Tech Continuous Pharma Production Lines Introduction
11.23.4 Zhejiang Canaan Tech Revenue in Continuous Pharma Production Lines Business (2021–2026)
11.23.5 Zhejiang Canaan Tech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
GEA Group
Glatt Group
IMA Group
LB Bohle
Hovione
Continuus Pharmaceuticals
Syntegon
Repligen
Dec Group
Recipharm
Shionogi
SK Biotek
KORSCH
Chemtrix
Fette Compacting
Gericke
Thermo Fisher Scientific
Coperion
Siemens AG
Copa-Data
Asymchem Laboratories (Tianjin)
Porton Pharma Solutions
Zhejiang Canaan Tech
List of Tables
 Table 1. Global Continuous Pharma Production Lines Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Integrated Systems
 Table 3. Key Players of Modular Systems
 Table 4. Global Continuous Pharma Production Lines Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Global Continuous Pharma Production Lines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Continuous Pharma Production Lines Market Size by Region (US$ Million), 2021–2026
 Table 7. Global Continuous Pharma Production Lines Market Share by Region (2021–2026)
 Table 8. Global Continuous Pharma Production Lines Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 9. Global Continuous Pharma Production Lines Market Share by Region (2027–2032)
 Table 10. Continuous Pharma Production Lines Market Trends
 Table 11. Continuous Pharma Production Lines Market Drivers
 Table 12. Continuous Pharma Production Lines Market Challenges
 Table 13. Continuous Pharma Production Lines Market Restraints
 Table 14. Global Continuous Pharma Production Lines Revenue by Players (US$ Million), 2021–2026
 Table 15. Global Continuous Pharma Production Lines Market Share by Players (2021–2026)
 Table 16. Global Top Continuous Pharma Production Lines Players by Tier (Tier 1, Tier 2, and Tier 3), based on Continuous Pharma Production Lines Revenue, 2025
 Table 17. Ranking of Global Top Continuous Pharma Production Lines Companies by Revenue (US$ Million) in 2025
 Table 18. Global 5 Largest Players Market Share by Continuous Pharma Production Lines Revenue (CR5 and HHI), 2021–2026
 Table 19. Global Key Players of Continuous Pharma Production Lines, Headquarters and Area Served
 Table 20. Global Key Players of Continuous Pharma Production Lines, Products and Applications
 Table 21. Global Key Players of Continuous Pharma Production Lines, Date of General Availability (GA)
 Table 22. Mergers and Acquisitions, Expansion Plans
 Table 23. Global Continuous Pharma Production Lines Market Size by Type (US$ Million), 2021–2026
 Table 24. Global Continuous Pharma Production Lines Revenue Market Share by Type (2021–2026)
 Table 25. Global Continuous Pharma Production Lines Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 26. Global Continuous Pharma Production Lines Revenue Market Share by Type (2027–2032)
 Table 27. Global Continuous Pharma Production Lines Market Size by Application (US$ Million), 2021–2026
 Table 28. Global Continuous Pharma Production Lines Revenue Market Share by Application (2021–2026)
 Table 29. Global Continuous Pharma Production Lines Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 30. Global Continuous Pharma Production Lines Revenue Market Share by Application (2027–2032)
 Table 31. North America Continuous Pharma Production Lines Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 32. North America Continuous Pharma Production Lines Market Size by Country (US$ Million), 2021–2026
 Table 33. North America Continuous Pharma Production Lines Market Size by Country (US$ Million), 2027–2032
 Table 34. Europe Continuous Pharma Production Lines Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. Europe Continuous Pharma Production Lines Market Size by Country (US$ Million), 2021–2026
 Table 36. Europe Continuous Pharma Production Lines Market Size by Country (US$ Million), 2027–2032
 Table 37. Asia-Pacific Continuous Pharma Production Lines Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Asia-Pacific Continuous Pharma Production Lines Market Size by Region (US$ Million), 2021–2026
 Table 39. Asia-Pacific Continuous Pharma Production Lines Market Size by Region (US$ Million), 2027–2032
 Table 40. Latin America Continuous Pharma Production Lines Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Latin America Continuous Pharma Production Lines Market Size by Country (US$ Million), 2021–2026
 Table 42. Latin America Continuous Pharma Production Lines Market Size by Country (US$ Million), 2027–2032
 Table 43. Middle East & Africa Continuous Pharma Production Lines Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Middle East & Africa Continuous Pharma Production Lines Market Size by Country (US$ Million), 2021–2026
 Table 45. Middle East & Africa Continuous Pharma Production Lines Market Size by Country (US$ Million), 2027–2032
 Table 46. GEA Group Company Details
 Table 47. GEA Group Business Overview
 Table 48. GEA Group Continuous Pharma Production Lines Product
 Table 49. GEA Group Revenue in Continuous Pharma Production Lines Business (US$ Million), 2021–2026
 Table 50. GEA Group Recent Development
 Table 51. Glatt Group Company Details
 Table 52. Glatt Group Business Overview
 Table 53. Glatt Group Continuous Pharma Production Lines Product
 Table 54. Glatt Group Revenue in Continuous Pharma Production Lines Business (US$ Million), 2021–2026
 Table 55. Glatt Group Recent Development
 Table 56. IMA Group Company Details
 Table 57. IMA Group Business Overview
 Table 58. IMA Group Continuous Pharma Production Lines Product
 Table 59. IMA Group Revenue in Continuous Pharma Production Lines Business (US$ Million), 2021–2026
 Table 60. IMA Group Recent Development
 Table 61. LB Bohle Company Details
 Table 62. LB Bohle Business Overview
 Table 63. LB Bohle Continuous Pharma Production Lines Product
 Table 64. LB Bohle Revenue in Continuous Pharma Production Lines Business (US$ Million), 2021–2026
 Table 65. LB Bohle Recent Development
 Table 66. Hovione Company Details
 Table 67. Hovione Business Overview
 Table 68. Hovione Continuous Pharma Production Lines Product
 Table 69. Hovione Revenue in Continuous Pharma Production Lines Business (US$ Million), 2021–2026
 Table 70. Hovione Recent Development
 Table 71. Continuus Pharmaceuticals Company Details
 Table 72. Continuus Pharmaceuticals Business Overview
 Table 73. Continuus Pharmaceuticals Continuous Pharma Production Lines Product
 Table 74. Continuus Pharmaceuticals Revenue in Continuous Pharma Production Lines Business (US$ Million), 2021–2026
 Table 75. Continuus Pharmaceuticals Recent Development
 Table 76. Syntegon Company Details
 Table 77. Syntegon Business Overview
 Table 78. Syntegon Continuous Pharma Production Lines Product
 Table 79. Syntegon Revenue in Continuous Pharma Production Lines Business (US$ Million), 2021–2026
 Table 80. Syntegon Recent Development
 Table 81. Repligen Company Details
 Table 82. Repligen Business Overview
 Table 83. Repligen Continuous Pharma Production Lines Product
 Table 84. Repligen Revenue in Continuous Pharma Production Lines Business (US$ Million), 2021–2026
 Table 85. Repligen Recent Development
 Table 86. Dec Group Company Details
 Table 87. Dec Group Business Overview
 Table 88. Dec Group Continuous Pharma Production Lines Product
 Table 89. Dec Group Revenue in Continuous Pharma Production Lines Business (US$ Million), 2021–2026
 Table 90. Dec Group Recent Development
 Table 91. Recipharm Company Details
 Table 92. Recipharm Business Overview
 Table 93. Recipharm Continuous Pharma Production Lines Product
 Table 94. Recipharm Revenue in Continuous Pharma Production Lines Business (US$ Million), 2021–2026
 Table 95. Recipharm Recent Development
 Table 96. Shionogi Company Details
 Table 97. Shionogi Business Overview
 Table 98. Shionogi Continuous Pharma Production Lines Product
 Table 99. Shionogi Revenue in Continuous Pharma Production Lines Business (US$ Million), 2021–2026
 Table 100. Shionogi Recent Development
 Table 101. SK biotek Company Details
 Table 102. SK biotek Business Overview
 Table 103. SK biotek Continuous Pharma Production Lines Product
 Table 104. SK biotek Revenue in Continuous Pharma Production Lines Business (US$ Million), 2021–2026
 Table 105. SK biotek Recent Development
 Table 106. Korsch Company Details
 Table 107. Korsch Business Overview
 Table 108. Korsch Continuous Pharma Production Lines Product
 Table 109. Korsch Revenue in Continuous Pharma Production Lines Business (US$ Million), 2021–2026
 Table 110. Korsch Recent Development
 Table 111. Chemtrix Company Details
 Table 112. Chemtrix Business Overview
 Table 113. Chemtrix Continuous Pharma Production Lines Product
 Table 114. Chemtrix Revenue in Continuous Pharma Production Lines Business (US$ Million), 2021–2026
 Table 115. Chemtrix Recent Development
 Table 116. Fette Compacting Company Details
 Table 117. Fette Compacting Business Overview
 Table 118. Fette Compacting Continuous Pharma Production Lines Product
 Table 119. Fette Compacting Revenue in Continuous Pharma Production Lines Business (US$ Million), 2021–2026
 Table 120. Fette Compacting Recent Development
 Table 121. Gericke Company Details
 Table 122. Gericke Business Overview
 Table 123. Gericke Continuous Pharma Production Lines Product
 Table 124. Gericke Revenue in Continuous Pharma Production Lines Business (US$ Million), 2021–2026
 Table 125. Gericke Recent Development
 Table 126. Thermo Fisher Scientific Company Details
 Table 127. Thermo Fisher Scientific Business Overview
 Table 128. Thermo Fisher Scientific Continuous Pharma Production Lines Product
 Table 129. Thermo Fisher Scientific Revenue in Continuous Pharma Production Lines Business (US$ Million), 2021–2026
 Table 130. Thermo Fisher Scientific Recent Development
 Table 131. Coperion Company Details
 Table 132. Coperion Business Overview
 Table 133. Coperion Continuous Pharma Production Lines Product
 Table 134. Coperion Revenue in Continuous Pharma Production Lines Business (US$ Million), 2021–2026
 Table 135. Coperion Recent Development
 Table 136. Siemens Company Details
 Table 137. Siemens Business Overview
 Table 138. Siemens Continuous Pharma Production Lines Product
 Table 139. Siemens Revenue in Continuous Pharma Production Lines Business (US$ Million), 2021–2026
 Table 140. Siemens Recent Development
 Table 141. Copa-DATA Company Details
 Table 142. Copa-DATA Business Overview
 Table 143. Copa-DATA Continuous Pharma Production Lines Product
 Table 144. Copa-DATA Revenue in Continuous Pharma Production Lines Business (US$ Million), 2021–2026
 Table 145. Copa-DATA Recent Development
 Table 146. Asymchem Laboratories(Tianjin) Company Details
 Table 147. Asymchem Laboratories(Tianjin) Business Overview
 Table 148. Asymchem Laboratories(Tianjin) Continuous Pharma Production Lines Product
 Table 149. Asymchem Laboratories(Tianjin) Revenue in Continuous Pharma Production Lines Business (US$ Million), 2021–2026
 Table 150. Asymchem Laboratories(Tianjin) Recent Development
 Table 151. Porton Pharma Solutions Company Details
 Table 152. Porton Pharma Solutions Business Overview
 Table 153. Porton Pharma Solutions Continuous Pharma Production Lines Product
 Table 154. Porton Pharma Solutions Revenue in Continuous Pharma Production Lines Business (US$ Million), 2021–2026
 Table 155. Porton Pharma Solutions Recent Development
 Table 156. Zhejiang Canaan Tech Company Details
 Table 157. Zhejiang Canaan Tech Business Overview
 Table 158. Zhejiang Canaan Tech Continuous Pharma Production Lines Product
 Table 159. Zhejiang Canaan Tech Revenue in Continuous Pharma Production Lines Business (US$ Million), 2021–2026
 Table 160. Zhejiang Canaan Tech Recent Development
 Table 161. Research Programs/Design for This Report
 Table 162. Key Data Information from Secondary Sources
 Table 163. Key Data Information from Primary Sources
 Table 164. Authors List of This Report


List of Figures
 Figure 1. Continuous Pharma Production Lines Picture
 Figure 2. Global Continuous Pharma Production Lines Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Continuous Pharma Production Lines Market Share by Type: 2025 vs 2032
 Figure 4. Integrated Systems Features
 Figure 5. Modular Systems Features
 Figure 6. Global Continuous Pharma Production Lines Market Size by Application (US$ Million), 2021–2032
 Figure 7. Global Continuous Pharma Production Lines Market Share by Application: 2025 vs 2032
 Figure 8. Pharmaceutical Companies Case Studies
 Figure 9. Contract Manufacturing Organization Case Studies
 Figure 10. Continuous Pharma Production Lines Report Years Considered
 Figure 11. Global Continuous Pharma Production Lines Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 12. Global Continuous Pharma Production Lines Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Continuous Pharma Production Lines Market Share by Region: 2025 vs 2032
 Figure 14. Global Continuous Pharma Production Lines Market Share by Players in 2025
 Figure 15. Global Continuous Pharma Production Lines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 16. The Top 10 and 5 Players Market Share by Continuous Pharma Production Lines Revenue in 2025
 Figure 17. North America Continuous Pharma Production Lines Market Size YoY Growth (US$ Million), 2021–2032
 Figure 18. North America Continuous Pharma Production Lines Market Share by Country (2021–2032)
 Figure 19. United States Continuous Pharma Production Lines Market Size YoY Growth (US$ Million), 2021–2032
 Figure 20. Canada Continuous Pharma Production Lines Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. Europe Continuous Pharma Production Lines Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Europe Continuous Pharma Production Lines Market Share by Country (2021–2032)
 Figure 23. Germany Continuous Pharma Production Lines Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. France Continuous Pharma Production Lines Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. U.K. Continuous Pharma Production Lines Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. Italy Continuous Pharma Production Lines Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Russia Continuous Pharma Production Lines Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Ireland Continuous Pharma Production Lines Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Asia-Pacific Continuous Pharma Production Lines Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Asia-Pacific Continuous Pharma Production Lines Market Share by Region (2021–2032)
 Figure 31. China Continuous Pharma Production Lines Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Japan Continuous Pharma Production Lines Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. South Korea Continuous Pharma Production Lines Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Southeast Asia Continuous Pharma Production Lines Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. India Continuous Pharma Production Lines Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Australia & New Zealand Continuous Pharma Production Lines Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Latin America Continuous Pharma Production Lines Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Latin America Continuous Pharma Production Lines Market Share by Country (2021–2032)
 Figure 39. Mexico Continuous Pharma Production Lines Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Brazil Continuous Pharma Production Lines Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Middle East & Africa Continuous Pharma Production Lines Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Middle East & Africa Continuous Pharma Production Lines Market Share by Country (2021–2032)
 Figure 43. Israel Continuous Pharma Production Lines Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Saudi Arabia Continuous Pharma Production Lines Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. UAE Continuous Pharma Production Lines Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. GEA Group Revenue Growth Rate in Continuous Pharma Production Lines Business (2021–2026)
 Figure 47. Glatt Group Revenue Growth Rate in Continuous Pharma Production Lines Business (2021–2026)
 Figure 48. IMA Group Revenue Growth Rate in Continuous Pharma Production Lines Business (2021–2026)
 Figure 49. LB Bohle Revenue Growth Rate in Continuous Pharma Production Lines Business (2021–2026)
 Figure 50. Hovione Revenue Growth Rate in Continuous Pharma Production Lines Business (2021–2026)
 Figure 51. Continuus Pharmaceuticals Revenue Growth Rate in Continuous Pharma Production Lines Business (2021–2026)
 Figure 52. Syntegon Revenue Growth Rate in Continuous Pharma Production Lines Business (2021–2026)
 Figure 53. Repligen Revenue Growth Rate in Continuous Pharma Production Lines Business (2021–2026)
 Figure 54. Dec Group Revenue Growth Rate in Continuous Pharma Production Lines Business (2021–2026)
 Figure 55. Recipharm Revenue Growth Rate in Continuous Pharma Production Lines Business (2021–2026)
 Figure 56. Shionogi Revenue Growth Rate in Continuous Pharma Production Lines Business (2021–2026)
 Figure 57. SK biotek Revenue Growth Rate in Continuous Pharma Production Lines Business (2021–2026)
 Figure 58. Korsch Revenue Growth Rate in Continuous Pharma Production Lines Business (2021–2026)
 Figure 59. Chemtrix Revenue Growth Rate in Continuous Pharma Production Lines Business (2021–2026)
 Figure 60. Fette Compacting Revenue Growth Rate in Continuous Pharma Production Lines Business (2021–2026)
 Figure 61. Gericke Revenue Growth Rate in Continuous Pharma Production Lines Business (2021–2026)
 Figure 62. Thermo Fisher Scientific Revenue Growth Rate in Continuous Pharma Production Lines Business (2021–2026)
 Figure 63. Coperion Revenue Growth Rate in Continuous Pharma Production Lines Business (2021–2026)
 Figure 64. Siemens Revenue Growth Rate in Continuous Pharma Production Lines Business (2021–2026)
 Figure 65. Copa-DATA Revenue Growth Rate in Continuous Pharma Production Lines Business (2021–2026)
 Figure 66. Asymchem Laboratories(Tianjin) Revenue Growth Rate in Continuous Pharma Production Lines Business (2021–2026)
 Figure 67. Porton Pharma Solutions Revenue Growth Rate in Continuous Pharma Production Lines Business (2021–2026)
 Figure 68. Zhejiang Canaan Tech Revenue Growth Rate in Continuous Pharma Production Lines Business (2021–2026)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Continuous Manufacturing lines for Pharma Market Research Report 2024
Global Continuous Processing Lines for Pharma Market Research Report 2024
Continuous Manufacturing in Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharma Continuous Blender Market Research Report 2024
Global Continuous Manufacturing Market Research Report 2024
Global Pharma Continuous Granulation Market Research Report 2024
Global Continuous Flow Chromatography System Market Research Report 2025
Global Pharmaceutical Production Equipment Market Research Report 2024
Global Pharmaceutical Flexible Manufacturing Systems Market Research Report 2025
Global Continuous Mixing Systems Market Research Report 2025
Global Pharmaceutical Manufacturing and Processing Equipment Market Research Report 2024
Global Drug Manufacturing Equipment Market Research Report 2024
Global Single use Continuous Chromatography Systems Market Research Report 2024
Global Automated Production Line Market Research Report 2024
Global Pharma 4 0 Market Research Report 2025
Global Sterile Injectables Production Line Market Research Report 2025
Global Pharma Tablet Coating Systems Market Research Report 2024
Global Pharmaceutical Supply Chain System Market Research Report 2024
Global Sterile Preparation Production Line Market Research Report 2024
Global IoT Spending for Connected Devices Platforms Digital Services in Pharmaceutical Manufacturing Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions